Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029968
Filing Date
2025-02-28
Accepted
2025-02-28 16:00:31
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lgvn-20241231.htm   iXBRL 10-K 3684477
2 EX-10.25 lgvn-ex10_25.htm EX-10.25 91687
3 EX-19.1 lgvn-ex19_1.htm EX-19.1 116570
4 EX-23.1 lgvn-ex23_1.htm EX-23.1 4884
5 EX-31.1 lgvn-ex31_1.htm EX-31.1 13297
6 EX-31.2 lgvn-ex31_2.htm EX-31.2 13317
7 EX-32.1 lgvn-ex32_1.htm EX-32.1 6072
8 EX-32.2 lgvn-ex32_2.htm EX-32.2 6153
9 GRAPHIC img51003162_0.jpg GRAPHIC 9151
10 GRAPHIC img51003162_1.jpg GRAPHIC 9151
11 GRAPHIC img51003162_2.jpg GRAPHIC 9151
12 GRAPHIC img156238889_0.jpg GRAPHIC 11414
13 GRAPHIC img237815897_0.jpg GRAPHIC 444907
  Complete submission text file 0000950170-25-029968.txt   12641459

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lgvn-20241231.xsd EX-101.SCH 1370514
87 EXTRACTED XBRL INSTANCE DOCUMENT lgvn-20241231_htm.xml XML 1626890
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40060 | Film No.: 25689820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)